- Home
- NEUP vs GLBZ Comparison
NEUP vs GLBZ Comparison
Compare NEUP & GLBZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEUP
- GLBZ
- Stock Information
- Founded
- NEUP 1996
- GLBZ 1949
- Country
- NEUP United States
- GLBZ United States
- Employees
- NEUP N/A
- GLBZ N/A
- Industry
- NEUP
- GLBZ Major Banks
- Sector
- NEUP
- GLBZ Finance
- Exchange
- NEUP Nasdaq
- GLBZ Nasdaq
- Market Cap
- NEUP 14.7M
- GLBZ 13.8M
- IPO Year
- NEUP N/A
- GLBZ N/A
- Fundamental
- Price
- NEUP $4.55
- GLBZ $4.67
- Analyst Decision
- NEUP Strong Buy
- GLBZ
- Analyst Count
- NEUP 2
- GLBZ 0
- Target Price
- NEUP $28.00
- GLBZ N/A
- AVG Volume (30 Days)
- NEUP 4.7M
- GLBZ 7.6K
- Earning Date
- NEUP 11-21-2025
- GLBZ 10-31-2025
- Dividend Yield
- NEUP N/A
- GLBZ N/A
- EPS Growth
- NEUP N/A
- GLBZ N/A
- EPS
- NEUP N/A
- GLBZ 0.01
- Revenue
- NEUP $15,649,448.00
- GLBZ $12,771,000.00
- Revenue This Year
- NEUP N/A
- GLBZ N/A
- Revenue Next Year
- NEUP N/A
- GLBZ N/A
- P/E Ratio
- NEUP N/A
- GLBZ $521.01
- Revenue Growth
- NEUP N/A
- GLBZ 13.82
- 52 Week Low
- NEUP $2.90
- GLBZ $3.89
- 52 Week High
- NEUP $126.00
- GLBZ $6.99
- Technical
- Relative Strength Index (RSI)
- NEUP 33.43
- GLBZ 51.42
- Support Level
- NEUP $4.53
- GLBZ $4.41
- Resistance Level
- NEUP $8.44
- GLBZ $4.89
- Average True Range (ATR)
- NEUP 1.19
- GLBZ 0.22
- MACD
- NEUP -1.03
- GLBZ -0.02
- Stochastic Oscillator
- NEUP 5.65
- GLBZ 59.81
About NEUP Neuphoria Therapeutics Inc.
Neuphoria Therapeutics Inc is a clinical-stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder. The Company operates through a single operating and reportable segment focused on the discovery and development of allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need.
About GLBZ Glen Burnie Bancorp
Glen Burnie Bancorp is a bank holding company for The Bank of Glen Burnie. It offers retail and commercial banking services such as checking, savings, loans, mobile banking, online banking, wire transfer, ACH services, debit cards, automated teller machines, and safe deposit boxes among others. The bank generates its revenue in the form of interest income. All of the revenues are earned within the United States.